{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:10:15Z","timestamp":1760148615620,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"],"award-info":[{"award-number":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Hubei Provincial Department of Science and Technology","award":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"],"award-info":[{"award-number":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"]}]},{"name":"School Natural Science Fund of Hubei University of Medicine","award":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"],"award-info":[{"award-number":["82204602","32170519","81973321","2022CFA956","2021QDJZR022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>Thermally processed Buthus martensii Karsch scorpion is an important traditional Chinese medical material that has been widely used to treat various diseases in China for over one thousand years. Our recent work showed that thermally processed Buthus martensii Karsch scorpions contain many degraded peptides; however, the pharmacological activities of these peptides remain to be studied. Here, a new degraded peptide, BmTX4-P1, was identified from processed Buthus martensii Karsch scorpions. Compared with the venom-derived wild-type toxin peptide BmTX4, BmTX4-P1 missed some amino acids at the N-terminal and C-terminal regions, while containing six conserved cysteine residues, which could be used to form disulfide bond-stabilized \u03b1-helical and \u03b2-sheet motifs. Two methods (chemical synthesis and recombinant expression) were used to obtain the BmTX4-P1 peptide, named sBmTX4-P1 and rBmTX4-P1. Electrophysiological experimental results showed that sBmTX4-P1 and rBmTX4-P1 exhibited similar activities to inhibit the currents of hKv1.2 and hKv1.3 channels. In addition, the experimental electrophysiological results of recombinant mutant peptides of BmTX4-P1 indicated that the two residues of BmTX4-P1 (Lys22 and Tyr31) were the key residues for its potassium channel inhibitory activity. In addition to identifying a new degraded peptide, BmTX4-P1, from traditional Chinese scorpion medicinal material with high inhibitory activities against the hKv1.2 and hKv1.3 channels, this study also provided a useful method to obtain the detailed degraded peptides from processed Buthus martensii Karsch scorpions. Thus, the study laid a solid foundation for further research on the medicinal function of these degraded peptides.<\/jats:p>","DOI":"10.3390\/toxins15050340","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T02:02:11Z","timestamp":1684116131000},"page":"340","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Functional Characterization of a New Degradation Peptide BmTX4-P1 from Traditional Chinese Scorpion Medicinal Material"],"prefix":"10.3390","volume":"15","author":[{"given":"Chenhu","family":"Qin","sequence":"first","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"},{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuhua","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Deng","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zuo","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Sun","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"},{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Cao","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"},{"name":"Center for BioDrug Research, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongyun","family":"Chen","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"},{"name":"Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hubei University of Medicine, Shiyan 442000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingliang","family":"Wu","sequence":"additional","affiliation":[{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, China"},{"name":"Center for BioDrug Research, Wuhan University, Wuhan 430072, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"ref_1","unstructured":"Chinese Pharmacopoeia Comission (2020). Chinese Pharmacopoeia (Part I), China Medical Science and Technology Press."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.toxicon.2010.02.019","article-title":"Two recombinant depressant scorpion neurotoxins differentially affecting mammalian sodium channels","volume":"55","author":"Yuan","year":"2010","journal-title":"Toxicon"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.peptides.2011.12.012","article-title":"Identification and molecular characterization of three new K+-channel specific toxins from the Chinese scorpion Mesobuthus martensii Karsch revealing intronic number polymorphism and alternative splicing in duplicated genes","volume":"34","author":"Zeng","year":"2012","journal-title":"Peptides"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bcp.2014.12.002","article-title":"Mesomartoxin, a new K(v)1.2-selective scorpion toxin interacting with the channel selectivity filter","volume":"93","author":"Wang","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e08560","DOI":"10.1016\/j.heliyon.2021.e08560","article-title":"Scorpion Venom peptide, AGAP inhibits TRPV1 and potentiates the analgesic effect of lidocaine","volume":"7","author":"Kampo","year":"2021","journal-title":"Heliyon"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Liu, Y., Li, Y., Zhu, Y., Zhang, L., Ji, J., Gui, M., Li, C., and Song, Y. (2021). Study of Anti-Inflammatory and Analgesic Activity of Scorpion Toxins DKK-SP1\/2 from Scorpion Buthus martensii Karsch (BmK). Toxins, 13.","DOI":"10.3390\/toxins13070498"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114998","DOI":"10.1016\/j.jep.2022.114998","article-title":"Makatoxin-3, a thermostable Nav1.7 agonist from Buthus martensii Karsch (BmK) scorpion elicits non-narcotic analgesia in inflammatory pain models","volume":"288","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.peptides.2019.02.009","article-title":"Peptides with therapeutic potential in the venom of the scorpion Buthus martensii Karsch","volume":"115","author":"Li","year":"2019","journal-title":"Peptides"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1097\/j.pain.0000000000002397","article-title":"A Buthus martensii Karsch scorpion sting targets Nav1.7 in mice and mimics a phenotype of human chronic pain","volume":"163","author":"Lu","year":"2022","journal-title":"Pain"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Zhao, F., Zou, X., Li, S., He, J., Xi, C., Tang, Q., Wang, Y., and Cao, Z. (2021). BmK NSPK, a Potent Potassium Channel Inhibitor from Scorpion Buthus martensii Karsch, Promotes Neurite Outgrowth via NGF\/TrkA Signaling Pathway. Toxins, 13.","DOI":"10.3390\/toxins13010033"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1021\/acs.jmedchem.9b01241","article-title":"Selective Blockade of Neuronal BK (alpha + beta4) Channels Preventing Epileptic Seizure","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","article-title":"Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease","volume":"38","author":"Chandy","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"103435","DOI":"10.1016\/j.jprot.2019.103435","article-title":"Thermostable potassium channel-inhibiting neurotoxins in processed scorpion medicinal material revealed by proteomic analysis: Implications of its pharmaceutical basis in traditional Chinese medicine","volume":"206","author":"Yang","year":"2019","journal-title":"J. Proteom."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1212\/WNL.0000000000003309","article-title":"Dominant KCNA2 mutation causes episodic ataxia and pharmacoresponsive epilepsy","volume":"87","author":"Corbett","year":"2016","journal-title":"Neurology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Helbig, K.L., Hedrich, U.B., Shinde, D.N., Krey, I., Teichmann, A.C., Hentschel, J., Schubert, J., Chamberlin, A.C., Huether, R., and Lu, H.M. (2016). A recurrent mutation in KCNA2 as a novel cause of hereditary spastic paraplegia and ataxia. Ann. Neurol., 80.","DOI":"10.1002\/ana.24762"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/brain\/awx184","article-title":"Clinical spectrum and genotype-phenotype associations of KCNA2-related encephalopathies","volume":"140","author":"Masnada","year":"2017","journal-title":"Brain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"eaaz4957","DOI":"10.1126\/scitranslmed.aaz4957","article-title":"4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy","volume":"13","author":"Hedrich","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1096\/fj.14-251967","article-title":"Kv1.3 channel-blocking immunomodulatory peptides from parasitic worms: Implications for autoimmune diseases","volume":"28","author":"Chhabra","year":"2014","journal-title":"FASEB J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhang, X., Liang, P., Zhang, Y., Wu, Y., Song, Y., Wang, X., Chen, T., Peng, B., Liu, W., and Yin, J. (2022). Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232314693"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"868842","DOI":"10.3389\/fncel.2022.868842","article-title":"Microglia-Mediated Inflammation and Neural Stem Cell Differentiation in Alzheimer\u2019s Disease: Possible Therapeutic Role of KV1.3 Channel Blockade","volume":"16","author":"Revuelta","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijbiomac.2021.02.155","article-title":"Different pharmacological properties between scorpion toxin BmKcug2 and its degraded analogs highlight the diversity of K(+) channel blockers from thermally processed scorpions","volume":"178","author":"Qin","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"30040","DOI":"10.1074\/jbc.M111258200","article-title":"kappa-Hefutoxin1, a novel toxin from the scorpion Heterometrus fulvipes with unique structure and function. Importance of the functional diad in potassium channel selectivity","volume":"277","author":"Srinivasan","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj20030115","article-title":"The \u2018functional\u2019 dyad of scorpion toxin Pi1 is not itself a prerequisite for toxin binding to the voltage-gated Kv1.2 potassium channels","volume":"377","author":"Mouhat","year":"2004","journal-title":"Biochem. J."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Qin, C., Yang, X., Zuo, Z., Yang, L., Yang, F., Cao, Z., Chen, Z., and Wu, Y. (2021). BmK86-P1, a New Degradation Peptide with Desirable Thermostability and Kv1.2 Channel-Specific Activity from Traditional Chinese Scorpion Medicinal Material. Toxins, 13.","DOI":"10.3390\/toxins13090610"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1111\/epi.17118","article-title":"Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants","volume":"63","author":"Miceli","year":"2022","journal-title":"Epilepsia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100834","DOI":"10.1016\/j.jbc.2021.100834","article-title":"Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo","volume":"297","author":"Smallwood","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"105776","DOI":"10.1016\/j.intimp.2019.105776","article-title":"PAP-1 ameliorates DSS-induced colitis with involvement of NLRP3 inflammasome pathway","volume":"75","author":"Mei","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mehy.2015.03.023","article-title":"Roles of lymphocyte Kv1.3-channels in gut mucosal immune system: Novel therapeutic implications for inflammatory bowel disease","volume":"85","author":"Kazama","year":"2015","journal-title":"Med. Hypotheses"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1158\/1078-0432.CCR-06-1940","article-title":"Expression of voltage-gated potassium channels in human and mouse colonic carcinoma","volume":"13","author":"Ousingsawat","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/sj.bjp.0705023","article-title":"Shaker-type Kv1 channel blockers increase the peristaltic activity of guinea-pig ileum by stimulating acetylcholine and tachykinins release by the enteric nervous system","volume":"138","author":"Oliveira","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/14656566.2018.1494728","article-title":"Linaclotide for the treatment of chronic constipation","volume":"19","author":"Bassotti","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"537508","DOI":"10.1155\/2015\/537508","article-title":"High Proteolytic Resistance of Spider-Derived Inhibitor Cystine Knots","volume":"2015","author":"Kikuchi","year":"2015","journal-title":"Int. J. Pept."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.3390\/toxins7104366","article-title":"The Cystine Knot Is Responsible for the Exceptional Stability of the Insecticidal Spider Toxin omega-Hexatoxin-Hv1a","volume":"7","author":"Herzig","year":"2015","journal-title":"Toxins"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.peptides.2012.11.013","article-title":"Fusion expression and purification of four disulfide-rich peptides reveals enterokinase secondary cleavage sites in animal toxins","volume":"39","author":"Chen","year":"2013","journal-title":"Peptides"}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/5\/340\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:34:59Z","timestamp":1760124899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/15\/5\/340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5]]}},"alternative-id":["toxins15050340"],"URL":"https:\/\/doi.org\/10.3390\/toxins15050340","relation":{},"ISSN":["2072-6651"],"issn-type":[{"type":"electronic","value":"2072-6651"}],"subject":[],"published":{"date-parts":[[2023,5,15]]}}}